Short Term Effects of Bariatric Surgeries on Renal and Hepatic Functions on Obese Morbid Patients

Santrauka

Background: Bariatric surgery has emerged as a well-established treatment for achieving long-lasting and successful weight reduction. Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are currently the most frequently done operations. The aim of this research was to investigate the hepatic and renal alterations following bariatric procedures, with a particular focus on SG. Methods: This observational prospective cohort research was performed on 100 morbidly obese individuals with BMI ≥40 kg/m2 who underwent SG. All patients were evaluated before surgery clinically and all laboratory investigations were done before operation as baseline, 3 months, 6 months after surgery, and after one year. Results: SGOT and SGPT were significantly decreased after 3 & 6 months with no significant difference after 12 months than 6 months. Bilirubin was significantly increased after 3 months than baseline then it was significantly decreased after 6 months than 3 months with no significant difference after 12 months than 6 months. Urea was significantly decreased after surgery through all time measurements. Creatinine was insignificantly different after 3 months than baseline while a significant decrease was achieved after 6 and 12 months. Conclusions: There was a significant improvement of renal and liver functions after SG in morbidly obese cases. Also, a significant improvement of lipid profile tests was observed.